Abstract
Common side effects of clofarabine (CFB) are liver toxicity, particularly a transient elevation of transaminases and skin toxicity. We studied the correlation of pharmacokinetic (PK) parameters with these toxicities and the efficacy of CFB in patients with relapsed or refractory acute myeloid leukemia. Clofarabine PK parameters showed large inter-individual variability. A higher CFB area under the curve was significantly associated with higher transaminase levels (p = .011 for aspartate aminotransferase (AST), adjusted for age, sex, cumulated CFB dosage, baseline AST, and glomerular filtration rate (GFR)). No significant association could be found between maximum concentration and the liver toxicity parameters. The occurrence of skin toxicity and the response to re-induction chemotherapy evaluated at day 15 were also not associated with PK. In conclusion, a higher individual CFB exposure is associated with increased liver toxicity reflected by elevated liver enzymes, without having an impact on anti-leukemic efficacy.
References
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P MoreauJ L Harousseau
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagop M KantarjianMichael Keating
Jun 7, 2003·Blood·Hagop KantarjianEmil J Freireich
Oct 11, 2003·Blood·Sima JehaHagop Kantarjian
Oct 16, 2004·Blood·Stefan FaderlHagop Kantarjian
Mar 4, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Peter L BonateJames Q Rose
Oct 20, 2005·Molecular Pharmacology·Karen M KingCarol E Cass
Sep 1, 2007·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Rajgopal GovindarajanJashvant D Unadkat
Nov 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Enric CarrerasUNKNOWN Spanish Myeloma Group/PETHEMA
Jun 21, 2008·Blood·Stefan FaderlHagop M Kantarjian
Nov 8, 2008·Pediatric Blood & Cancer·Steven G DuBoisUNKNOWN Children's Oncology Group
Jul 7, 2009·Biochemical Pharmacology·Anna ZhenchukFreidoun Albertioni
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sima JehaPeter Steinherz
Jun 29, 2010·Cancer Chemotherapy and Pharmacology·Peter L BonateSteve Weitman
Jan 22, 2011·Leukemia·S S FaragD R Jones
Mar 23, 2011·Cancer·Chadi NabhanParameswaran Venugopal
Jul 14, 2011·Cancer·Stefan FaderlHagop M Kantarjian
Aug 16, 2011·Blood·John MagenauShin Mineishi
Nov 15, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Koen van BesienAndrew S Artz
May 16, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan FaderlHagop M Kantarjian
Jan 21, 2014·Clinical Lymphoma, Myeloma & Leukemia·Stefan FaderlHagop M Kantarjian
Jun 9, 2014·Cancer Chemotherapy and Pharmacology·Bingnan ZhangNikolai Podoltsev
Aug 19, 2015·Leukemia·J M MiddekeJ Schetelig
Apr 10, 2016·Journal of Pharmaceutical and Biomedical Analysis·Božena BüttnerHolger Knoth
Citations
Oct 23, 2019·American Journal of Hematology·Elizabeth F KrakowBrenda M Sandmaier
Jan 21, 2021·Bone Marrow Transplantation·A B VersluysK Mellgren
May 26, 2020·Clinics and Research in Hepatology and Gastroenterology·Sayed Aliul Hasan AbdiAbdulaziz Al Zahrani